Back
Standard BioTools, Inc. 10K Form
Sell
17
LAB
Standard BioTools, Inc.
Last Price:
$1.06
Seasonality Move:
-3.5%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LAB News And Ratings
See the #1 stock for the next 7 days that we like better than LAB
LAB Financial Statistics
Sales & Book Value
| Annual Sales: | $85.3M |
|---|---|
| Cash Flow: | $-1.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.04 |
| Price / Book: | 1.02 |
Profitability
| EPS (TTM): | -0.19720 |
|---|---|
| Net Income (TTM): | $-61.5M |
| Gross Margin: | $37.1M |
| Return on Equity: | -14.14% |
| Return on Assets: | -10.76% |
Standard BioTools, Inc. Earnings Forecast
Key Standard BioTools, Inc. Financial Ratios
-
The Gross Profit Margin over the past 20 years for LAB is 43.50%.
-
The Selling, General & Administrative Expenses for LAB have been equal to 128.75% of Gross Profit Margin.
-
The Research & Development expenses have been 29.07% of Revenue.
-
The Net Earning history of LAB is -68.94% of Total Revenues.
-
Per Share Earnings over the last 20 years have been positive in 13 years.
Standard BioTools, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | LAB |
| Website: | standardbio.com |
Debt
| Debt-to-Equity Ratio: | 0.07 |
|---|---|
| Current Ratio: | 4.19 |
| Quick Ratio: | 1.86 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 39 |
LAB Technical Analysis vs Fundamental Analysis
Sell
17
Standard BioTools, Inc. (LAB)
is a Sell
Is Standard BioTools, Inc. a Buy or a Sell?
-
Standard BioTools, Inc. stock is rated a SellThe current Standard BioTools, Inc. [LAB] share price is $1.06. The Score for LAB is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.